Effect of pentoxifylline on diaphragmatic contractility in septic rats

Acta Medica Okayama

Volumn 62, Issue 2, 2008, Pages 101-107

  Danjo, Wataru ^a   Fujimura, Naoyuki ^a   Ujike, Yoshihito ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

CAMP; Diaphragm; Endotoxin; MDA; Pentoxifylline; TNF

Indexed keywords

RATTUS;

CYCLIC AMP; ENDOTOXIN; FREE RADICAL; MALONALDEHYDE; PENTOXIFYLLINE; SCAVENGER; TUMOR NECROSIS FACTOR ALPHA; VASODILATOR AGENT;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DIAPHRAGM; DRUG EFFECT; MALE; METABOLISM; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; RAT; SEPSIS; WISTAR RAT;

ANIMALS; CYCLIC AMP; DIAPHRAGM; ENDOTOXINS; FREE RADICAL SCAVENGERS; FREE RADICALS; MALE; MALONDIALDEHYDE; MUSCLE CONTRACTION; PENTOXIFYLLINE; RANDOM ALLOCATION; RATS; RATS, WISTAR; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 45149099033     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hussain SN: Respiratory muscle dysfunction in sepsis. Mol Cell Biochem (1998) 179: 125-134.
2. Boczkowski J, Dureuil B, Branger C, Pavlovic D, Murciano D, Pariente R and Aubier M: Effects of sepsis on diaphragmatic function in rats. Am Rev Respir Dis (1988) 138: 260-265.
3. Supinski G, Nethery D and DiMarco A: Effect of free radical scavengers on endotoxin-induced respiratory muscle dysfunction. Am Rev Respir Dis (1993) 148: 1318-1324.
4. Wilcox PG, Wakai Y, Walley KR, Cooper DJ and Road J: Tumor necrosis factor alpha decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med (1994) 150: 1368-1373.
5. Shindoh C, Hida W, Ohkawara Y, Yamauchi K, Ohno I, Takishima T and Shirato K: TNF-alpha mRNA expression in diaphragm muscle after endotoxin administration. Am J Respir Crit Care Med (1995) 152: 1690-1696.
6. Goode HF and Webster NR: Free radicals and antioxidants in sepsis. Crit Care Med (1993) 21: 1770-1776.
7. Shindoh C, Dimarco A, Nethery D and Supinski G: Effect of PEG-superoxide dismutase on the diaphragmatic response to endotoxin. Am Rev Respir Dis (1992) 145: 1350-1354.
8. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, Scogin JT and Strandness DE: Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J (1982) 104: 66-72.
9. Lauterbach R and Zembala M: Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis: Eur J Pediatr (1996) 155: 404-409.
10. Zeni F, Pain P, Vindimian M, Gay JP, Gery P, Bertrand M, Page Y, Page D, Vermesch R and Bertrand JC: Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study. Crit Care Med (1996) 24: 207-214.
11. Bacher A, Mayer N, Klimscha W, Oismuller C, Steltzer H and Hammerle A: Effects of pentoxifylline on hemodynamics and oxygenation in septic and nonseptic patients. Crit Care Med (1997) 25: 795-800.
12. Staubach KH, Schroder J, Stuber F, Gehrke K, Traumann E and Zabel P: Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study. Arch Surg (1998) 133: 94-100.
13. Lauterbach R, Pawlik D, Kowalczyk D, Ksycinski W, Helwich E and Zembala M: Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med (1999) 27: 807-814.
14. Schade UF: Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor. Circ Shock (1990) 31: 171-181.
15. Wu CC, Liao MH, Chen SJ and Yen MH: Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia. Eur J Pharmacol (1999) 373: 41-49.
16. Coimbra R, Melbostad H and Hoyt DB: Effects of phosphodiesterase inhibition on the inflammatory response after shock: role of pentoxifylline. J Trauma (2004) 56: 442-449.
17. van Leenen D, van der Poll T, Levi M, ten Cate H, van Deventer SJ, Hack CE, Aarden LA and ten Cate JW: Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol (1993) 151: 2318-2325.
18. Lowry OH, Rosebrough NJ, Farr AL and Randall RL: Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 193: 265-275.
19. Fujimura N, Sumita S, Aimono M, Masuda Y, Shichinohe Y, Narimatsu E and Namiki A: Effect of free radical scavengers on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med (2000) 162: 2159-2165.
20. Fujimura N, Sumita S, Narimatsu E, Nakayama Y, Shitinohe Y and Namiki A: Effects of isoproterenol on diaphragmatic contractility in septic peritonitis. Am J Respir Crit Care Med (2000) 161: 440-446.
21. Beutler B and Kruys V: Lipopolysaccharide signal transduction, regulation of tumor necrosis factor biosynthesis, and signaling by tumor necrosis factor itself.J Cardiovasc Pharmacol (1995) 25 Suppl 2: S1-8.
22. Diaz PT, Julian MW, Wewers MD and Clanton TL: Tumor necrosis factor and endotoxin do not directly affect in vitro diaphragm function. Am Rev Respir Dis (1993) 148: 281-287.
23. Van Surell C, Boczkowski J, Pasquier C, Du Y, Franzini E and Aubier M: Effects of N-acetylcysteine on diaphragmatic function and malondialdehyde content in Escherichia coli endotoxemic rats. Am Rev Respir Dis (1992) 146: 730-734.
24. Fujimura N, Sumita S and Narimatsu E: Alteration in diaphragmatic contractility during septic peritonitis in rats: effect of polyethylene glycol-absorbed superoxide dismutase: Crit Care Med (2000)28: 2406-2414.
25. Shindoh C, DiMarco A, Thomas A, Manubay P and Supinski G: Effect of N-acetylcysteine on diaphragm fatigue. J Appl Physiol (1990)68: 2107-2113.
26. Supinski G, Nethery D, Stofan D and DiMarco A: Effect of free radical scavengers on diaphragmatic fatigue. Am J Respir Crit Care Med (1997) 155: 622-629.
27. Travaline JM, Sudarshan S, Roy BG, Cordova F, Leyenson V and Criner GJ: Effect of N-acetylcysteine on human diaphragm strength and fatigability. Am J Respir Crit Care Med (1997) 156: 1567-1571.
28. Nethery D, DiMarco A, Stofan D and Supinski G: Sepsis increases contraction-related generation of reactive oxygen species in the diaphragm. J Appl Physiol (1999)87: 1279-1286.
29. Supinski G, Nethery D, Stofan D and DiMarco A: Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles. J Appl Physiol (1996) 81: 1370-1378.
30. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G and Summer W: Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci (1990) 47: 1023-1029.
31. Bessler H, Gilgal R, Djaldetti M and Zahavi I: Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol (1986) 40: 747-754.
32. Franzini E, Sellak H, Marquetty C, Babin-Chevaye C, Hakim J and Pasquier C: Inhibition of human neutrophil binding to hydrogen peroxide-treated endothelial cells by cAMP and hydroxyl radical scavengers. Free Radic Biol Med (1996) 21: 15-23.
33. Van Der Heijden HF, Zhan WZ, Prakash YS, Dekhuijzen PN and Sieck GC: Salbutamol enhances isotonic contractile properties of rat diaphragm muscle. J Appl Physiol (1998) 85: 525-529.
34. Uzuki M, Yamakage M, Fujimura N and Namiki A: Preferable inotropic action of procaterol, a potent bronchodilator, on impaired diaphragmatic contractility in an intraabdominal septic model. J Anesth (2006) 20: 145-148.
35. Raju PI, Tolman KC, Davis PJ, Ludden TM, Roy TK and Johnson FE: Distribution and metabolism of pentoxifylline in non-tumor-bearing mice. J Med (1993) 24: 353-368.
36. Honess DJ, Dennis IF and Bleehen NM: Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice. Radiother Oncol (1993) 28: 208-218.